This prospective randomized controlled study was intended to assess the effects of different doses of clopidogrel plus early rehabilitation therapy on motor function and inflammatory factors in patients with ischemic stroke. Between August 2018 and October 2020, 90 cases of ischemic stroke treated in the Second People’s Hospital of Yibin were randomized at a ratio of 1 : 1 to receive either oral 50 mg/d clopidogrel plus early rehabilitation therapy (low-dose group) or oral 75 mg/d clopidogrel plus early rehabilitation therapy (high-dose group), with 45 cases in each group. The outcome measures including the Barthel Index (BI), National Institutes of Health Stroke Scale (NIHSS), Fugl-Meyer simplified scale, hypersensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and occurrence of adverse events were collected. After treatment, the high-dose group had higher BI results than the low-dose group. All eligible patients showed significantly declined NIHSS scores, and the high-dose group had markedly lower results ( P < 0.05 ). After treatment, the Fugl-Meyer scores of both upper and lower extremities of the high-dose group were significantly higher than those in the low-dose group. The high-dose group achieved a greater decrease in inflammatory factor levels after treatment versus the low-dose group. The two groups showed a similar incidence of adverse events. High-dose clopidogrel plus early rehabilitation outperforms the low-dose treatment for patients with ischemic stroke by effectively mitigating the inflammatory response in the body, promoting the restoration of neurological function, improving the level of motor function, and enhancing the patient’s quality of life, with manageable safety.
A compact CPW-fed triple-band Multiple Input Multiple Output (MIMO) antenna is designed for WLAN, WiMAX, and 5G applications in this article. Three resonant frequencies, including 2.4 GHz, 3.5 GHz, and 5.5 GHz are generated by two branches and a rectangle radiation patch. The proposed antenna comprises two antenna elements placed side by side with a meandering neutralization line (NL) inserted between the elements to realize decoupling. To analyze the performance, it is fabricated and experimented. The measured results reveal that it has three impedance bandwidths: 2.38-2.52 GHz (5.7%), 3.28-3.62 GHz (10.1%), and 5.05-6.77 GHz (29.1%) with the measured isolation up to 16 dB. Furthermore, the parameters of diversity performance like envelope correlation coefficient (ECC), diversity gain (DG), efficiency, gain, channel capacity loss (CCL), mean effective gain (MEG), and total active reflection coefficient (TARC) are also analyzed, and the results indicate that the proposed antenna is desirable for integration in WLAN/WiMAX/5G devices.
A dual-band four-element MIMO antenna was designed and fabricated with enhanced isolation. The introduced antenna was fed by a coplanar waveguide (CPW) and consisted of four identical monopole antenna elements placed perpendicular to each other. A cross-shaped stub and orthogonal placement of four elements were introduced for high isolation. Modified ground structure was used for extending bandwidths. The measured results demonstrate that the introduced antenna has double bands (S11 < −10 dB) covering 3.28–4.15 GHz and 4.69–6.01 GHz, with fractional bandwidths of 23.4% and 24.7% and a high isolation S21, S31 better than 19 dB. The curves of the envelope correlation coefficient (ECC) and diversity gain (DG) were less than 0.0025 and higher than 9.999, respectively, indicating a low correlation between antenna elements. Furthermore, gain, efficiency, channel capacity loss (CCL), total active reflection coefficient (TARC) and mean effective gain (MEG) have all been investigated over the operating band to determine the antenna’s diversity performance. In accordance with the simulated and measured results, it confirms that the proposed antenna is appropriate for 5G applications.
BackgroundExcision repair cross-complementing group 1 (ERCC1) was considered a potential candidate gene for ischemic stroke, and its polymorphisms might be associated with the susceptibility to ischemic stroke.MethodsA total of 513 patients with ischemic stroke and 550 control subjects were recruited. The expression levels of ERCC1 messenger RNA (mRNA) in peripheral blood mononuclear cells and its protein in plasma were detected by quantitative real-time PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Rs3212986 polymorphism of ERCC1 was detected by PCR-restriction fragment length polymorphism (RFLP-PCR) and was confirmed by sequencing. The association between the ERCC1 rs3212986 polymorphism or its expression and ischemic stroke was further analyzed.ResultsThe ERCC1 mRNA level in patients with ischemic stroke was lower than that in the control group (P < 0.05). However, the ERCC1 protein level in patients with ischemic stroke was higher than that in the control group (P < 0.05). The A allele of rs3212986 was associated with increased ischemic stroke risk (OR = 1.287, 95% CI = 1.076–1.540, P = 0.006). The association between rs3212986 polymorphism and ischemic stroke susceptibility was found in both recessive (OR = 2.638, 95% CI = 1.744–3.989, P < 0.001) and additive models (OR = 1.309, 95% CI = 1.028–1.667, P = 0.031), respectively. Similar results were obtained in the recessive model (OR = 2.015, 95% CI = 1.087–3.704, P = 0.026) after adjusting for demographic information and other variables. Additionally, the level of ERCC1 mRNA in the CC/CA genotype was higher than that in the AA genotype (P < 0.05).ConclusionIt was suggested that the ERCC1 rs3212986 polymorphism was associated with ischemic stroke susceptibility in a Chinese Han population and that an A allele of rs3212986 was related to increased ischemic stroke risk. The altered ERCC1 expression level caused by the rs3212986 polymorphism might participate in the pathophysiological process of ischemic stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.